Last week we began our focus on health issues faced by minority women. About 10-20% of breast cancers -- more than one out of every 10 -- are found to be triple-negative. Triple-negative breast cancer is not likely fueled by hormones or the HER2 protein, and is not expected to respond to hormonal therapies or therapies that target HER2 receptors. If you have triple-negative breast cancer, you might be wondering what treatment options you DO have. Do some chemotherapy combinations work better than others? Should you ask your doctor about getting chemo before surgery? What new research is being done on triple-negative treatment? BreastCancer.org will host an Ask-the-Expert online conference tonight on triple negative breast cancer from 7:00-8:00 pm. Just go to the BreastCancer.org homepage and click the "Join Conference" button.
Triple Negative Breast Cancer: Online Conference
July 15, 2008 By Leave a Comment



Follow Us!